Table 2 Clinical features of mice receiving donor cells from MOG 35-55 -immunized, vehicle-treated or mepazine-treated mice
Donor cells | Incidence | Day of disease onset | Mean maximal clinical score |
|---|---|---|---|
Vehicle | 100% (5/5) | 21.0 ± 1.5 | 4.4 ± 0.3 |
Mepazine | 60% (3/5) | 17.7 ± 1.3 | 2.5 ± 0.7 |